BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park CH, Jeong SH, Yim HW, Kim JD, Bae SH, Choi JY, Yoon SK. Family history influences the early onset of hepatocellular carcinoma. World J Gastroenterol 2012; 18(21): 2661-2667 [PMID: 22690075 DOI: 10.3748/wjg.v18.i21.2661] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Ugai T, Sasamoto N, Lee HY, Ando M, Song M, Tamimi RM, Kawachi I, Campbell PT, Giovannucci EL, Weiderpass E, Rebbeck TR, Ogino S. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol 2022. [PMID: 36068272 DOI: 10.1038/s41571-022-00672-8] [Reference Citation Analysis]
2 Kalpadakis S, Sifaki-pistolla D, Symvoulakis EK, Kelefiotis-stratidakis P, Vamvakas L, Mavroudis D, Lionis C. Reporting Liver Cancer Trends in the Island of Crete, Greece: Results from a Geo-Epidemiological Study. IJERPH 2022;19:10166. [DOI: 10.3390/ijerph191610166] [Reference Citation Analysis]
3 Oh H, Lee HY, Kim J, Kim YJ. Systematic Review with Meta-Analysis: Comparison of the Risk of Hepatocellular Carcinoma in Antiviral-Naive Chronic Hepatitis B Patients Treated with Entecavir versus Tenofovir: The Devil in the Detail. Cancers (Basel) 2022;14:2617. [PMID: 35681596 DOI: 10.3390/cancers14112617] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kawanaka M, Nishino K, Kawamoto H, Haruma K. Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases. World J Gastroenterol 2021; 27(43): 7497-7508 [PMID: 34887645 DOI: 10.3748/wjg.v27.i43.7497] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Diallo I, Ndiaye B, Touré M, Sow A, Mbengue A, Diawara PS, Gning SB, Mbaye PS, Fall F, Mbengue M. Hepatocellular carcinoma in Senegal: epidemiological, clinical and etiological aspects about 229 cases at Hôpital Principal de Dakar. Pan Afr Med J 2021;38:99. [PMID: 33889265 DOI: 10.11604/pamj.2021.38.99.25195] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
6 Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology. Japan Society of Hepatology Guidelines for the Management of Hepatitis B Virus Infection: 2019 update. Hepatol Res 2020;50:892-923. [PMID: 32343469 DOI: 10.1111/hepr.13504] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
7 Chook JB, Ngeow YF, Tee KK, Lee JWT, Mohamed R. Increased Coffee Intake Reduces Circulating HBV DNA and HBsAg Levels in HBeAg-Negative Infection: A Cohort Study. Viruses 2019;11:E808. [PMID: 31480588 DOI: 10.3390/v11090808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Weledji EP. Familial hepatocellular carcinoma: 'A model for studying preventive and therapeutic measures'. Ann Med Surg (Lond) 2018;35:129-32. [PMID: 30305894 DOI: 10.1016/j.amsu.2018.09.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Chung JW, Park JJ, Lim YJ, Lee J, Kim SM, Han JH, Jeon SR, Lee HS, Kim YS, Song SY; Committee of Education and Ethics of the Korean Society of Gastrointestinal Cancer. Gastrointestinal cancer risk in patients with a family history of gastrointestinal cancer. Korean J Gastroenterol 2018;71:338-48. [PMID: 29943561 DOI: 10.4166/kjg.2018.71.6.338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Li RD, Tang YH, Wang HL, Yang D, Sun LJ, Li W. The SMYD3 VNTR 3/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population. Pathol Res Pract 2018;214:625-30. [PMID: 29691085 DOI: 10.1016/j.prp.2018.04.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
11 Chandra S, Kusum A, Chandra H, Yadav K, Verma SK. Familial Hepatocellular Carcinoma- First Reported Case from India. J Clin Diagn Res 2016;10:ED11-2. [PMID: 27134884 DOI: 10.7860/JCDR/2016/17746.7427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
12 Xiao L, Zhang RL, Zhang H, Tulahong A, Zhang YF, Wen H, Bao YX. Comparison of the clinical characteristics and survival between Uyghur patients with hepatitis virus-related and non-B, non-C hepatocellular carcinoma in Xinjiang, China. Chin J Cancer Res 2015;27:279-87. [PMID: 26157324 DOI: 10.3978/j.issn.1000-9604.2015.01.04] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Liu L, Li L, Zhou S, Jiang Q, Chen S, Gao Y, Chen Y. Familial correlations of onset age of hepatocellular carcinoma: a population-based case-control family study. PLoS One 2014;9:e108391. [PMID: 25247419 DOI: 10.1371/journal.pone.0108391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
14 Fernández-Rodríguez CM, Gutiérrez-García ML. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B. World J Gastrointest Pharmacol Ther 2014; 5(3): 175-182 [PMID: 25133046 DOI: 10.4292/wjgpt.v5.i3.175] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
15 Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology. JSH Guidelines for the Management of Hepatitis B Virus Infection. Hepatol Res. 2014;44 Suppl S1:1-58. [PMID: 24397839 DOI: 10.1111/hepr.12269] [Cited by in Crossref: 103] [Cited by in F6Publishing: 103] [Article Influence: 12.9] [Reference Citation Analysis]